Medivolve Inc
OTC:MEDVF

Watchlist Manager
Medivolve Inc Logo
Medivolve Inc
OTC:MEDVF
Watchlist
Price: 0.007 USD 16.67% Market Closed
Market Cap: 22.8m USD
Have any thoughts about
Medivolve Inc?
Write Note

Medivolve Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medivolve Inc
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Medivolve Inc
OTC:MEDVF
Change in Working Capital
CA$1.5m
CAGR 3-Years
-13%
CAGR 5-Years
36%
CAGR 10-Years
N/A
A
Andlauer Healthcare Group Inc
TSX:AND
Change in Working Capital
-CA$26.9m
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WELL Health Technologies Corp
TSX:WELL
Change in Working Capital
-CA$20.7m
CAGR 3-Years
-121%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
dentalcorp Holdings Ltd
TSX:DNTL
Change in Working Capital
-CA$81.6m
CAGR 3-Years
14%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
KDA Group Inc
XTSX:KDA
Change in Working Capital
-CA$3.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Healwell Al Inc
TSX:AIDX
Change in Working Capital
CA$1.1m
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medivolve Inc
Glance View

Market Cap
22.8m USD
Industry
Health Care

Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. The company offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. The company is also engaged in developing technologies to identify, treat, and prevent medical issues. The company provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The firm uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.

MEDVF Intrinsic Value
0.004 USD
Overvaluation 49%
Intrinsic Value
Price

See Also

What is Medivolve Inc's Change in Working Capital?
Change in Working Capital
1.5m CAD

Based on the financial report for Dec 31, 2023, Medivolve Inc's Change in Working Capital amounts to 1.5m CAD.

What is Medivolve Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
36%

Over the last year, the Change in Working Capital growth was -88%. The average annual Change in Working Capital growth rates for Medivolve Inc have been -13% over the past three years , 36% over the past five years .

Back to Top